89 related articles for article (PubMed ID: 21668072)
1. Use of albumin in patients with cirrhosis: misuse or misconception?
Kumar R
Natl Med J India; 2011; 24(2):123-4. PubMed ID: 21668072
[No Abstract] [Full Text] [Related]
2. Is albumin infusion necessary after large volume paracentesis?
Cárdenas A; Ginès P; Runyon BA
Liver Int; 2009 May; 29(5):636-40; discussion 640-1. PubMed ID: 19413666
[No Abstract] [Full Text] [Related]
3. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
4. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis.
Kumar R; Kumar S; Lata S
Med Hypotheses; 2013 Apr; 80(4):452-5. PubMed ID: 23375411
[TBL] [Abstract][Full Text] [Related]
5. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis.
Kwok CS; Krupa L; Mahtani A; Kaye D; Rushbrook SM; Phillips MG; Gelson W
Biomed Res Int; 2013; 2013():295153. PubMed ID: 24222902
[TBL] [Abstract][Full Text] [Related]
6. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
[TBL] [Abstract][Full Text] [Related]
7. Midodrine for paracentesis-induced circulatory dysfunction.
Bai M; Han G
J Clin Gastroenterol; 2014 Mar; 48(3):300. PubMed ID: 24100756
[No Abstract] [Full Text] [Related]
8. Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?
Burroughs AK
Dig Liver Dis; 2003 Sep; 35(9):664-7. PubMed ID: 14563191
[TBL] [Abstract][Full Text] [Related]
9. In response.
Elbaz AA;
J Clin Gastroenterol; 2014 Mar; 48(3):300-1. PubMed ID: 24202000
[No Abstract] [Full Text] [Related]
10. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
11. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
13. Comment to "Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses".
Pariente A
Dig Liver Dis; 2012 Jun; 44(6):535. PubMed ID: 22387284
[No Abstract] [Full Text] [Related]
14. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
[TBL] [Abstract][Full Text] [Related]
15. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
17. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Schneditz D; Bachler I; Stadlbauer V; Stauber RE
Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
19. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study.
Lata J; Marecek Z; Fejfar T; Zdenek P; Brůha R; Safka V; Hůlek P; Hejda V; Dolina J; Stehlík J; Tozzi I
Hepatogastroenterology; 2007; 54(79):1930-3. PubMed ID: 18251131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
